Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03685448
Title ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) (UNICAB)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Australian and New Zealand Urogenital and Prostate Cancer Trials Group

papillary renal cell carcinoma

renal carcinoma

chromophobe renal cell carcinoma

sarcomatoid renal cell carcinoma



Age Groups: senior | adult
Covered Countries

No variant requirements are available.